Anshul Parulkar, MD

Banker turned physician, aspiring cardiologist. Married to @SanchitaMD. Opinions are my own.

[Ursanex @UrsanexAdvisors]

We thank ⁦⁦@RILifeSciHub⁩ for their support for and trust in us as we build towards a more innovative RI! 🚀 https://t.co/DPIncfmNU6

[Ursanex @UrsanexAdvisors]

Calling all physicians who regularly wear surgical masks/N95s! 😷

We're connecting top minds with a promising startup for a high-impact advisory role. Trainees & attendings welcome! If you want to shape healthcare while getting compensated for your expertise, DM us for details.

[Sachit Singal, MD @SachitSingalMD]

🚨 New in @JCardFail — using data from @CCCTNetwork, we describe differences in modes of death in patients with cardiogenic shock.

https://t.co/B5cS7tdAiU

Thank you to @ddbergMD, @EBohula, Dr. David Morrow, and others in @TIMIStudyGroup for your mentorship and support!

[Ursanex @UrsanexAdvisors]

Excited to join forces and get to work! @nemichealth @DrParulkar

[Anshul Parulkar, MD @DrParulkar]

Thrilled to have pitched our software startup, KardioStatus, at the Innovation Showcase at Venture Cafe Providence this past week! ⁦@nemichealth⁩ ⁦@CommerceRI⁩ ⁦⁦@vencafePVD⁩

[Sachit Singal, MD @SachitSingalMD]

A pleasure to be among such incredible talent driving the field forward at #AHA23, and an honor to present original investigative work from @TIMIStudyGroup and @CCCTNetwork

Special shout-out to my incredible mentors for their support and guidance!

[TIMI Study Group @TIMIStudyGroup]

Among patients with established ASCVD, a CAD polygenic risk score was associated with incident complex coronary revascularization procedures. @SachitSingalMD @BrianBergmark @marstonMD #AHA23

[TIMI Study Group @TIMIStudyGroup]

Don't miss @SachitSingalMD 's presentation on CAD Polygenic Risk Score and Incident Complex Coronary Revascularization in Adults With Atherosclerosis, in 24 hrs in Sci & Tech Hall Zone 2 @giorgiomelloni @rgiugliano @marstonMD @BrianBergmark #AHA23

[TIMI Study Group @TIMIStudyGroup]

In a nested prospective study of modes of in-hospital deaths in pts w/cardiogenic shock, heterogeneity in pts w/preceding cardiac arrest may have important implications for future clinical trial design @SachitSingalMD @ddbergMD @ebohula @CCCTNetwork #AHA23

[TIMI Study Group @TIMIStudyGroup]

Dr. Sachit Singal presents his work on Modes of In-Hospital Death in Patients With Cardiogenic Shock (CS): An Analysis From the Critical Care Cardiology Trials Network (CCCTN), in 24 hrs in 103C @CCCTNetwork @BrighamMedRes @SachitSingalMD #AHA23

[Anshul Parulkar, MD @DrParulkar]

Excited to launch our new venture, KardioStatus. Check out our article in the Brown Daily Herald!

https://t.co/GiGQ1q9lmO

[Anshul Parulkar, MD @DrParulkar]

If you are a physician looking to get involved or an early-stage venture in need of clinical consulting services, check out https://t.co/ZFe1t4EQ9c

More announcements soon!

[Ursanex @UrsanexAdvisors]

We’re excited to share that Ursanex is live! We are a physician-founded advisory network that provides clinical due diligence to ventures within the life sciences, healthtech, and digital health spaces.

To learn more, visit https://t.co/p2WAcZadSe.

More exciting news to come!

[Sachit Singal, MD @SachitSingalMD]

A few months ago, I was asked to share some thoughts with the next class of trainees as a column in @BrighamWomens Clinical and Research News. Hope intern year is off to a great start for many of you!

https://t.co/DxqsTX7B17

[Anshul Parulkar, MD @DrParulkar]

So pumped to have matched at @BrownCardiology and have a chance to train alongside my wife @SanchitaMD! So it begins 😁